Zheng Quan Shi Bao Wang·2025-10-31 10:04Core Insights - The avian influenza concept sector saw a rise of 3.32%, ranking 6th among concept sectors, with 24 stocks increasing in value, including notable gains from Zhongsheng Pharmaceutical and Lianhuan Pharmaceutical, which hit the daily limit, and Hualan Vaccine and Dongfang Bio, which rose by 17.88%, 7.24%, and 6.41% respectively [1] Group 1: Market Performance - The avian influenza concept sector attracted a net inflow of 811 million yuan from major funds, with 16 stocks receiving net inflows, and 9 stocks exceeding 10 million yuan in net inflow [1] - Lianhuan Pharmaceutical led the net inflow with 349 million yuan, followed by Zhongsheng Pharmaceutical, Hualan Vaccine, and Wens Foodstuff, which received net inflows of 305 million yuan, 64 million yuan, and 58 million yuan respectively [1] Group 2: Fund Flow Ratios - Lianhuan Pharmaceutical, Zhongsheng Pharmaceutical, and Hualan Vaccine had the highest net inflow ratios, at 41.17%, 20.95%, and 13.04% respectively [2] - The trading turnover rates for these companies were 13.81% for Lianhuan Pharmaceutical, 10.14% for Zhongsheng Pharmaceutical, and 3.99% for Hualan Vaccine [2]